| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5B | $7.4B | $7.1B | $7.4B | $6.0B | $4.7B | $1.2B | $1.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.2B | $0.3B | $1.1B | $1.0B | $0.6B | $0.1B | $0.2B |
| Net Income | $0.1B | $0.1B | $0.2B | $0.8B | $0.7B | $0.4B | $0.1B | $0.2B |
| EPS (Basic) | $0.41 | $0.73 | $1.35 | $4.75 | $4.48 | $2.42 | $0.40 | $0.87 |
| EPS (Diluted) | $0.41 | $0.73 | $1.34 | $4.73 | $4.45 | $2.40 | $0.39 | $0.86 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.0B | $12.7B | $12.9B | $11.0B | $10.7B | $8.5B | $8.3B | $7.9B |
| Current Assets | $0.9B | $1.4B | $1.7B | $1.5B | $1.4B | $0.9B | $0.9B | $0.9B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $4.9B | $5.6B | $5.8B | $4.0B | $4.1B | $2.6B | $2.6B | $2.4B |
| Current Liabilities | $1.0B | $1.7B | $1.8B | $0.9B | $1.1B | $0.8B | $1.0B | $0.6B |
| Stockholders' Equity | $7.1B | $7.1B | $7.1B | $6.9B | $6.5B | $5.9B | $5.7B | $5.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $0.8B | $1.2B | $1.4B | $1.2B | $0.9B | $0.8B | $0.9B |
| Investing Cash Flow | $-0.5B | $-0.8B | $-1.2B | $-0.6B | $-1.8B | $-0.5B | $-0.6B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-0.1B | $0.2B | $-0.8B | $0.8B | $-0.4B | $-0.2B | $-0.3B |